Overview


According to FutureWise analysis the market for Abdominal Aortic Aneurysm Treatment in 2023 is US$ 2.42 billion, and is expected to reach US$ 3.64 billion by 2031 at a CAGR of 5.20%.

Abdominal aortic aneurysm (AAA) refers to the dilation of the aorta, the vital blood vessel that delivers oxygenated blood to the abdomen and lower body. Specifically, an AAA occurs when a section of the aorta becomes weakened and dilated, resembling a balloon-like bulge. While AAA often does not exhibit symptoms, it can pose a significant risk if not addressed promptly. This condition can cause severe internal bleeding and also can potentially lead to fatal consequences.

The treatment options for AAA depend on factors such as the size, growth rate, and overall health of the individual. For small AAAs that are not rapidly growing, a monitoring approach may be taken, with regular imaging tests to track any changes. Medications are not available to shrink or eliminate an existing AAA, but they may be prescribed to manage associated risk factors such as high blood pressure and cholesterol. Surgical intervention is typically recommended for larger or rapidly growing AAAs to prevent rupture. There are two types of surgical options for treating larger AAA, which are open repair and endovascular aneurysm repair (EVAR). Open repair involves making an incision to directly access the aneurysm and using a graft to repair it. On the other hand, EVAR is a less invasive procedure where a catheter is used to place a stent graft in the weakened area of the aorta.

FutureWise Market Research has published a report that provides an insightful analysis of Abdominal Aortic Aneurysm Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Abdominal Aortic Aneurysm Treatment Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  •  Novartis Pharmaceuticals
  •  Merck & Co., Inc.
  •  Bristol-Myers
  •  Abbott
  •  AbbVie Inc.
  •  Celgen Corporation
  •  Amgen Inc.
  •  Teva pharmaceutical Industries Ltd.
  •  Pfizer Inc.
  •  Sanofi
  •  GlaxoSmithKline
  •  Pharmaceuticals Limited
  •  Mylan N.V.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in theAbdominal Aortic Aneurysm Treatment Market:

  • In February 2023, Cereno Scientific has recently shared updates on their Phase II study of the drug candidate CS1, which targets the rare disease pulmonary arterial hypertension (PAH). All clinical sites involved in the study have been activated and are currently recruiting patients. So far, three patients have been randomly selected and are undergoing treatment. The study is expected to deliver top-line results by the end of 2023.

The market for abdominal aortic aneurysm treatment is fueled by several factors, such as rising prevalence of atherosclerosis and an aging population. As this condition becomes more common, individuals are seeking effective treatment options, which is driving market expansion. Technological advancements are also shaping the market. Advanced medical technologies have revolutionized the treatment of AAA, with minimally invasive endovascular repair techniques. These techniques offer patients less invasive and innovative treatment options. These advancements have significantly impacted the market driving the overall growth of the abdominal aortic aneurysm treatment market. The growing awareness about the importance of early diagnosis and screening for abdominal aortic aneurysm is another key dynamic. Increased awareness campaigns and initiatives have improved detection rates, allowing for timely intervention and better treatment outcomes. The presence of favorable reimbursement policies is also a significant dynamic influencing the market. Adequate reimbursement and insurance coverage for abdominal aortic aneurysm treatments incentivizes healthcare providers and patients to opt for advanced treatment options, driving market growth and ensuring accessibility to appropriate care. Despite the availability of several treatment options, the healthcare market faces some limitations. The high cost of some treatments may prevent certain patients from accessing the necessary care. 

By Treatment

  •  Surgery
    •  Open surgery
    •  Endovascular aneurysr
  •  Medication
    •  Antihypertensive
    •  Antilipidemics

By End User Type

  •  Hospitals
  •  Clinics

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America held the largest market share in the abdominal aortic aneurysm treatment market due to the rising prevalence of atherosclerosis. Atherosclerosis is an inflammatory illness that causes plaque to compile in the arteries, including the abdominal aorta. This plaque accumulation can harm the arteries and impede the regular flow of blood. The increasing occurrence of atherosclerosis in the area has resulted in a higher need for efficient remedies for abdominal aortic aneurysm, which is driving the expansion of the market. Furthermore, the market expansion for treating abdominal aortic aneurysm has been influenced by the increased funding for R&D activities. These efforts by the public and private organizations have resulted in incredible advancements in surgical techniques, endovascular repair options, and innovative devices, leading to better outcomes for patients and an array of treatment options. The continuous R&D efforts by key market players in North America are further fueling the market's expansion. In Europe, the cases of cardiovascular disease, including abdominal aortic aneurysm, are also evaluated to increase. Factors such as sedentary lifestyles, unhealthy eating habits, and an aging population contribute to the rising prevalence of CVDs. This is projected to drive the demand for effective treatments for abdominal aortic aneurysm in the region.

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Abdominal Aortic Aneurysm Treatment Market By Treatment, By End User Type And By Region
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Abdominal Aortic Aneurysm Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Abdominal Aortic Aneurysm Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Abdominal Aortic Aneurysm Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Abdominal Aortic Aneurysm Treatment Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Surgery
         1.1. Open surgery
         1.2. Endovascular aneurysr
        2. Medication
         2.1. Antihypertensive
         2.2. Antilipidemics

  • 8.   Abdominal Aortic Aneurysm Treatment Market, By End User Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics

  • 9.   North America Abdominal Aortic Aneurysm Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Abdominal Aortic Aneurysm Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Abdominal Aortic Aneurysm Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Abdominal Aortic Aneurysm Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Abdominal Aortic Aneurysm Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Novartis Pharmaceuticals
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merck & Co., Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bristol-Myers
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Abbott
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. AbbVie Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Celgen Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Amgen Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Teva pharmaceutical Industries Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Pfizer Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Sanofi
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. GlaxoSmithKline
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Pharmaceuticals Limited
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Mylan N.V.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Abdominal Aortic Stent Graft Market

Read More

Abdominal Aortic Aneurysm Repair Devices Market

Read More

Endovascular Abdominal Aortic Aneurysm Repair Devices Market

Read More
Partner

Our Clients